CompaniesBoston Biomedical

Boston Biomedical

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedTerminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (7)
View all

Total Trials

7

As Lead Sponsor

3

As Collaborator

4

Total Enrollment

233

By Phase

NA: 3

By Status

COMPLETED: 3WITHDRAWN: 1UNKNOWN: 1SUSPENDED: 1TERMINATED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
NCT04312763
NCT04100720
Hover over trial bars to see details

Recent Trials

NCT04100720Lead Sponsor
Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
NAWithdrawn
Started: Feb 29, 2024 · Completed: Dec 31, 2030
NCT04409561Collaborator
Reference Range for abioSCOPE® Device With the PSP Assay in a Generally Healthy Adult Population
N/ACompleted
150 participants
Started: Nov 15, 2021 · Completed: Jan 15, 2022
NCT04658017Lead Sponsor
GARNET™ Filter (GARNET Device) IDE Used in Chronic Hemodialysis Patients With a Bloodstream Infection
NAUnknown
15 participants
Started: Mar 15, 2021 · Completed: Dec 31, 2021
NCT04312763Collaborator
A Validation of the Functional Low-Vision Observer Rated Assessment (FLORA-20) for Profoundly Blind Individuals
N/ASuspended
3 participants
Started: Mar 6, 2020 · Completed: Feb 20, 2025
NCT04260620Collaborator
Delphinus SoftVue™ ROC Reader Study (DMT SV RRS3)
N/ACompleted
32 participants
Started: Feb 8, 2020 · Completed: Mar 3, 2020
View all 7 trials →
Funding History (1)
D
Jun 15, 2010
Filing